FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

11551011000001104: Budenofalk 2mg foam enema (Dr. Falk Pharma UK Ltd) 14 dose (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
42343501000001111 Budenofalk 2mg foam enema (Dr. Falk Pharma UK Ltd) 14 dose (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
42343601000001110 Budenofalk 2mg foam enema (Dr. Falk Pharma UK Ltd) 14 dose en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Budenofalk 2mg foam enema (Dr. Falk Pharma UK Ltd) 14 dose Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Budenofalk 2mg foam enema (Dr. Falk Pharma UK Ltd) 14 dose Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Budenofalk 2mg foam enema (Dr. Falk Pharma UK Ltd) 14 dose Is a Budesonide 2mg foam enema 14 dose true Inferred relationship Existential restriction modifier
Budenofalk 2mg foam enema (Dr. Falk Pharma UK Ltd) 14 dose Is pack of Budenofalk 2mg foam enema (Dr. Falk Pharma UK Ltd) false Inferred relationship Existential restriction modifier
Budenofalk 2mg foam enema (Dr. Falk Pharma UK Ltd) 14 dose Has active ingredient Budesonide false Inferred relationship Existential restriction modifier
Budenofalk 2mg foam enema (Dr. Falk Pharma UK Ltd) 14 dose Has manufactured dose form Foam false Inferred relationship Existential restriction modifier
Budenofalk 2mg foam enema (Dr. Falk Pharma UK Ltd) 14 dose Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Budenofalk 2mg foam enema (Dr. Falk Pharma UK Ltd) 14 dose Has excipient Sorbic acid true Inferred relationship Existential restriction modifier
Budenofalk 2mg foam enema (Dr. Falk Pharma UK Ltd) 14 dose Has excipient Edetate disodium false Inferred relationship Existential restriction modifier
Budenofalk 2mg foam enema (Dr. Falk Pharma UK Ltd) 14 dose Has excipient Cetyl alcohol false Inferred relationship Existential restriction modifier
Budenofalk 2mg foam enema (Dr. Falk Pharma UK Ltd) 14 dose VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Budenofalk 2mg foam enema (Dr. Falk Pharma UK Ltd) 14 dose VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Budenofalk 2mg foam enema (Dr. Falk Pharma UK Ltd) 14 dose Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Budenofalk 2mg foam enema (Dr. Falk Pharma UK Ltd) 14 dose Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Budenofalk 2mg foam enema (Dr. Falk Pharma UK Ltd) 14 dose Has AMP Budenofalk 2mg foam enema (Dr. Falk Pharma UK Ltd) true Inferred relationship Existential restriction modifier
Budenofalk 2mg foam enema (Dr. Falk Pharma UK Ltd) 14 dose Has specific active ingredient Budesonide true Inferred relationship Existential restriction modifier
Budenofalk 2mg foam enema (Dr. Falk Pharma UK Ltd) 14 dose Has dispensed dose form Foam true Inferred relationship Existential restriction modifier
Budenofalk 2mg foam enema (Dr. Falk Pharma UK Ltd) 14 dose Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start